0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita]
RxNorm concept 2627717, branded drug (sbd). Prescribable name: AMJEVITA 20 MG in 0.4 ML Prefilled Syringe.
- RxCUI
- 2627717
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2627717 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
0.4 ML Amjevita 50 MG/ML Prefilled Syringe; Amjevita 20 MG per 0.4 ML Prefilled Syringe
Related concepts
- adalimumab-atto 50 MG/ML (SCDC, consists of)
- adalimumab-atto 50 MG/ML [Amjevita] (SBDC, consists of)
- Prefilled Syringe (DF, has dose form)
- Amjevita (BN, has ingredient)
- 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2627717 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2627717 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2627717. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.